What is CVE-2022-1067?

CVE-2022-1067 is a medium-severity vulnerability in Lifepoint Patient Portal, classified under Authentication Bypass Using an Alternate Path or Channel. CVSS score: 6.5/10. Published 2022-04-11.

How severe is CVE-2022-1067?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Auth bypass in Lifepoint Patient Portal

CVE-2022-1067

Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.

Published 2022-04-11 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.009 (57.7th percentile), scored 2026-10-02.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 58th percentile — 57.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.009 · newest: 0.009 · change: 0.000

Affected products

Lifepoint Patient Portal
Lifepoint Informatics Patient Portal — versions All

Weakness classification (CWE)

References

www.cisa.gov/uscert/ics/advisories/icsma-22-095-01 (US Government Resource, Third Party Advisory)

Frequently asked questions

What is CVE-2022-1067?: CVE-2022-1067 is a medium-severity vulnerability in Lifepoint Patient Portal, classified under Authentication Bypass Using an Alternate Path or Channel. CVSS score: 6.5/10. Published 2022-04-11.
How severe is CVE-2022-1067?: Medium severity. CVSS v3 base score is 6.5 out of 10.